Arcadia Biosciences Stock Analysis

Arcadia Stock Analysis Notes

The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Arcadia Biosciences recorded a loss per share of 6.77. The entity last dividend was issued on the 24th of January 2018. The firm had 1:40 split on the 1st of March 2023. Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. The company was incorporated in 2002 and is headquartered in Davis, California. Arcadia Bio operates under Agricultural Inputs classification in the United States and is traded on NASDAQ Exchange. It employs 58 people. To find out more about Arcadia Biosciences contact Stanley Jacot at 214 974 8921 or learn more at https://www.arcadiabio.com.

Arcadia Biosciences Investment Alerts

Arcadia Biosciences Upcoming and Recent Events

Arcadia Largest EPS Surprises

View All Earnings Estimates

Arcadia Biosciences Environmental, Social, and Governance (ESG) Scores

Arcadia Biosciences Thematic Classifications

Arcadia Stock Institutional Investors

Note, although Arcadia Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Arcadia Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.3 M.

Arcadia Profitablity

The company has Profit Margin (PM) of (1.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.15) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.15.

Management Efficiency

Arcadia Biosciences has return on total asset (ROA) of (0.4471) % which means that it has lost $0.4471 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6708) %, meaning that it created substantial loss on money invested by shareholders. Arcadia Biosciences' management efficiency ratios could be used to measure how well Arcadia Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of March 24, 2025, Return On Tangible Assets is expected to decline to -0.67. In addition to that, Return On Capital Employed is expected to decline to -1.04. At present, Arcadia Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 5.5 M, whereas Non Currrent Assets Other are forecasted to decline to about 2.5 M.

Technical Drivers

As of the 24th of March, Arcadia Biosciences shows the mean deviation of 2.82, and Risk Adjusted Performance of (0.19). In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Arcadia Biosciences, as well as the relationship between them.

Arcadia Biosciences Price Movement Analysis

Arcadia Biosciences Insider Trading Activities

Arcadia Biosciences Outstanding Bonds

Arcadia Biosciences Predictive Daily Indicators

Arcadia Biosciences Corporate Filings

Arcadia Biosciences Forecast Models

Arcadia Biosciences' time-series forecasting models are one of many Arcadia Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arcadia Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Arcadia Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Arcadia shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Arcadia Biosciences. By using and applying Arcadia Stock analysis, traders can create a robust methodology for identifying Arcadia entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Arcadia analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Arcadia analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Arcadia Biosciences stock analysis indicators help investors evaluate how Arcadia Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Arcadia Biosciences shares will generate the highest return on investment. By understating and applying Arcadia Biosciences stock analysis, traders can identify Arcadia Biosciences position entry and exit signals to maximize returns.

When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.